Eculizumab during Pregnancy in a Patient with Treatment-Refractory Myasthenia Gravis: A Case Report

The recombinant humanized monoclonal antibody eculizumab has been shown to be effective and well tolerated in patients with anti-acetylcholine receptor antibody-positive, treatment-refractory generalized myasthenia gravis (gMG). Myasthenia gravis (MG) often affects women of child-bearing potential....

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Tuan, Harvey, Brittany, Suresh, Niraja, Farias, Jerrica, Gooch, Clifton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case − General Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923701/
https://www.ncbi.nlm.nih.gov/pubmed/33708096
http://dx.doi.org/10.1159/000511957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923701/
https://www.ncbi.nlm.nih.gov/pubmed/33708096
http://dx.doi.org/10.1159/000511957

Ejemplares similares